Search results :

Rosiglitazone

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: A10BG02

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9
Anaemia common, 7.1% x x x x x x x x x
Nasopharyngitis 6.3% - 6.9% x x x
Upper respiratory tract infection 4.3% - 9.9% 8.7% x x x
Hypertension 4.4% - 6.1% x x x x
Headache 5.4% - 20% 5% x x x x x x x x x
Thrombocytopenia common x
Back pain 4% - 9% 3.8% x x x x x x x x
Arthralgia 4.2% - 5% x x x
Hyperglycaemia 3.9% - 10% 5.7% x x x x x x x x
Fatigue 1.9% - 9% 5% x x x x x x x x
Sinusitis 3% - 12% 4.5% x x x x x x x x
Diarrhoea 2.3% - 35% 3.3% x x x x x x x x
Hypoglycaemia 1% - 13% 0.2% x x x x x x x x x
Anaphylactic shock very rare, postmarketing x x x x x
Angioedema very rare, postmarketing x x x x x x
Rash very rare, postmarketing x x x x x
Cardiac failure congestive postmarketing, rare x x x x x x x x
Hepatitis postmarketing x x x x x x x
Pleural effusion postmarketing x x x x x x x
Pruritus very rare, postmarketing x x x x x
Pulmonary oedema postmarketing, rare x x x x x x x x
Stevens-Johnson syndrome postmarketing x x x
Urticaria very rare, postmarketing x x x x x x
Hepatic failure postmarketing x x x x x x x x
Hepatic function abnormal rare x
Fatal outcomes postmarketing x x x x x
Visual acuity reduced postmarketing x x x x
Macular oedema postmarketing, rare x x x x x
Worsening of diabetes postmarketing x x x
Weight increased very rare x x x
Infection x x x x x
Connective tissue disorder x
Constipation x x
Diabetes mellitus x
Dizziness x
Oedema x x x x x x x x x
Eye disorder x
Fracture x x x x x
Gastrointestinal disorder x
Cardiac disorder x
Cardiac failure x x x x x x
Hyperbilirubinaemia x x x x x x x x
Hypercholesterolaemia x
Hyperlipidaemia x
Hypertriglyceridaemia x
Immune system disorder x
Ischaemia x
Leukopenia x
Myocardial infarction x x
Nausea x x x
Nervous system disorder x
Sprain x
Cerebrovascular accident x
Oedema peripheral x
Myocardial ischaemia x x
Ketonuria x x x
Malnutrition x
Myalgia x
Volume plasma increased x x x x x x x x
Increased appetite x x
Hepatic enzyme increased x
Hepatobiliary disease x
Fluid retention x
Parotid gland enlargement x
Anion gap increased x x x
Haematocrit decreased x
Blood and lymphatic system disorders x
High cholesterol x x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

rosiglitazone / rosiglitazone

Side effects:38
Source:EMA

ROSIGLITAZONE MALEATE / AVANDIA

Side effects:13
Source:FDA

rosiglitazone maleate / Avandia

Side effects:18
Source:FDA

ROSIGLITAZONE MALEATE / AVANDIA

Side effects:18
Source:FDA

ROSIGLITAZONE MALEATE / AVANDIA

Side effects:20
Source:FDA

ROSIGLITAZONE

Side effects:34
Source:FDA Structured Product Label

ROSIGLITAZONE

Side effects:34
Source:FDA Structured Product Label

ROSIGLITAZONE

Side effects:39
Source:FDA Structured Product Label

ROSIGLITAZONE (ROSIGLITAZONE MALEATE) / AVANDIA 8MG

Side effects:40
Source:Health Canada

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label